PGP and cancer: The authors found that ten of these analogs significantly increased rhodamine 123 accumulation inside cultured lymphocytes and six of them were able to strongly inhibit P-gp activity, being promising candidates, together with fluphenazine, for adjuvant cancer therapies [26].